Scarica l'app Stockscreener
20.50
0.64%
0.13
Dopo l'orario di chiusura:
20.70
0.20
+0.98%
Galecto Inc Borsa (GLTO) Ultime notizie
What risks investors should watch in Galecto Inc. stock2025 Year in Review & Consistent Growth Equity Picks - ulpravda.ru
Is Galecto Inc. stock attractive for hedge fundsJuly 2025 Breakouts & Daily Price Action Insights - ulpravda.ru
Is Galecto Inc. stock supported by innovation pipeline2025 Risk Factors & Fast Gain Swing Alerts - ulpravda.ru
Should I hold or sell Galecto Inc. stock in 2025July 2025 Patterns & High Conviction Investment Ideas - ulpravda.ru
Galecto (NASDAQ:GLTO) Now Covered by Leerink Partners - Defense World
Leerink Partners Initiates Coverage of Galecto (GLTO) with Outperform Recommendation - Nasdaq
Leerink Partners Initiates Coverage on GLTO with 'Outperform' Ra - GuruFocus
Leerink Partners initiates coverage on Galecto stock with Outperform rating By Investing.com - Investing.com Nigeria
Leerink Partners initiates coverage on Galecto stock with Outperform rating - Investing.com India
Galecto strengthens its leadership after recent acquisition in the US - medwatch.com
Galecto Appoints Sherwin Sattarzadeh as Chief Operating Officer - MarketScreener
Galecto appoints new chief operating officer, enhances leadership - TipRanks
Galecto announces key additions to leadership team - MarketScreener
Galecto appoints Sherwin Sattarzadeh as chief operating officer and issues warrant - Investing.com
Galecto, Inc. Appoints New Chief Operating Officer - TradingView — Track All Markets
Galecto Announces Key Additions to Leadership Team - The Manila Times
Galecto (GLTO) grants large warrant and hires new Chief Operating Officer - Stock Titan
Galecto, Inc. Appoints Sherwin Sattarzadeh as Chief Operating Officer and Becker Hewes as Chief Medical Officer, Effective January 5, 2026 - MarketScreener
Galecto appoints former Blueprint Medicines executives as COO and CMO - MSN
Comparing Galecto (NASDAQ:GLTO) and Avidity Biosciences (NASDAQ:RNA) - Defense World
Is the Market Bullish or Bearish on Galecto Inc? - Benzinga
Galecto Files to Register 60.5 Million Shares for Secondary Offering - MarketScreener
Galecto (NASDAQ:GLTO) Shares Down 13.3%Time to Sell? - MarketBeat
Galecto (NASDAQ:GLTO) Shares Down 13.3% – Time to Sell? - Defense World
[EFFECT] Galecto, Inc. SEC Filing - Stock Titan
Ideas Watch: Should I hold or sell Galecto Inc stock in 2025 - moha.gov.vn
Why Galecto Inc. stock could benefit from AI revolution2025 Market WrapUp & Free Expert Approved Momentum Trade Ideas - Улправда
Galecto (GLTO) Price Target Increased by 12.50% to 36.72 - Nasdaq
How Galecto Inc. stock performs after earningsQuarterly Profit Summary & Reliable Breakout Forecasts - Улправда
How rising interest rates impact Galecto Inc. stock2025 Winners & Losers & Reliable Trade Execution Plans - DonanımHaber
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Galecto, Inc. announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Galecto (NASDAQ:GLTO) Price Target Raised to $36.00 at Guggenheim - Defense World
Guggenheim Maintains Galecto (GLTO) Buy Recommendation - Nasdaq
Guggenheim raises Galecto stock price target to $36 on positive ASH25 data - Investing.com Nigeria
Galecto (GLTO) Rating Maintained by Guggenheim, Price Target Rai - GuruFocus
Galecto (NASDAQ:GLTO) Upgraded to “Hold” at Wall Street Zen - Defense World
Galecto (GLTO) Price Target Increased by 433.33% to 32.64 - Nasdaq
Guggenheim Begins Coverage on Galecto (NASDAQ:GLTO) - Defense World
Galecto, Inc. (GLTO) -5.1% in After-hours: What’s Driving the Move? - Stocks Telegraph
Galecto, Inc. (GLTO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Galecto (GLTO) Stock Analysis Report | Financials & Insights - Benzinga
Guggenheim Initiates Coverage of Galecto (GLTO) with Buy Recommendation - Nasdaq
Galecto (GLTO) Receives "Buy" Rating from Guggenheim | GLTO Stoc - GuruFocus
Guggenheim Initiates Coverage on Galecto With Buy Rating, $32 Price Target - marketscreener.com
Guggenheim initiates Galecto stock with Buy rating on DMR-001 potential - Investing.com
Guggenheim initiates Galecto stock with Buy rating on DMR-001 potential By Investing.com - Investing.com India
Profit Review: Why Galecto Inc. stock could benefit from AI revolution2025 Key Lessons & Growth Oriented Trading Recommendations - moha.gov.vn
Its Stock Has Paid Off Big Time For Galecto Inc - setenews.com
Mintz Advises Galecto, Inc. in its acquisition of Damora Therapeutics, Inc. and its concurrent $285 million private placement - Mintz
Galecto (NASDAQ:GLTO) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Can Galecto Inc. stock deliver surprise earnings beatJuly 2025 Review & Reliable Price Breakout Alerts - newser.com
Galecto, Inc. announced that it has received $284.999961 million in funding from a group of investors - marketscreener.com
Is Galecto Inc. stock gaining market shareJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
Can Galecto Inc. stock weather global recessionTrade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):